Back to NBIX overview

NBIX Neurocrine Biosciences PE ratio, current and historical analysis

As of Jun 18, 2024, the NBIX stock has a PE ratio of 34.71. The calculation is based on the latest EPS of $3.77 and the stock price of $130.86 per share. A decrease of 30% has been observed in the PE ratio compared to its average of 49.2 of the last four quarters.

NBIX PE ratio history

How has NBIX's PE ratio performed in the past

The mean historical PE ratio of Neurocrine Biosciences over the last six years is 203.02. The current 34.71 P/E ratio is 83% lower than the historical average. Looking back at the last six years, NBIX's PE ratio peaked in the Sep 2018 quarter at 1,229.5, with a price of $122.95 and an EPS of $0.1. The Sep 2021 quarter marked the lowest point at 20.11, with a price of $95.91 and an EPS of $4.77.

Average
203.02
Median
81.92
Minimum
20.11
Maximum
1,229.5

Neurocrine Biosciences PE ratio by year

Maximum annual increase: 309.73% in 2021

Maximum annual decrease: -91.86% in 2020

Year PE ratio Change
2023 51.47 -30.62%
2022 74.19 -17.24%
2021 89.65 309.73%
2020 21.88 -91.86%
2019 268.73 -13.45%
2018 310.48 N/A
2017 N/A N/A
2016 N/A N/A
2015 N/A N/A
2014 N/A N/A

NBIX average PE ratio chart

What is the average PE ratio of NBIX for the past years

NBIX's current PE ratio is lower than its 3, 5 and 10-year averages.

3-year avg
133.68
5-year avg
146.33
10-year avg
203.02
15-year avg
164.01

NBIX PE vs peers

What is NBIX's PE ratio compared to its peers

In comparison to its peers LLY and ABBV, NBIX's PE ratio is lower, but it is higher than RPRX's.

Stock name PE ratio Market cap
RPRX Royalty Pharma plc 14.71 $15.73B
NBIX Neurocrine Biosciences Inc 35.29 $13.39B
ANIP Ani Pharmaceuticals Inc 37.04 $1.26B
ABBV AbbVie Inc 50.82 $302.41B
LLY ELI LILLY & Co 131.7 $853.66B
RGEN Repligen Corp 415.86 $6.51B
PFE Pfizer Inc N/A $156.51B
PTN Palatin Technologies Inc N/A $31.56M
CASI CASI Pharmaceuticals Inc N/A $36.12M

Frequently asked questions

What is Neurocrine Biosciences's PE ratio?

The price to earnings ratio for NBIX stock is 34.71 as of Jun 18, 2024.

What is the 3-year average PE ratio for Neurocrine Biosciences (NBIX)?

Over the last 3 years, the average price to earnings ratio for NBIX stock is 133.68.

What is the 5-year average PE ratio for Neurocrine Biosciences (NBIX)?

Over the last 5 years, the average price to earnings ratio for NBIX stock is 146.33.

What is the highest PE ratio for NBIX?

The highest quarterly PE ratio in the last six years has been 1,229.5 and it was in the Sep 2018 quarter.

How does the current PE ratio for NBIX compare to its historical average?

NBIX's current price to earnings ratio is 83% below its 6-year historical average.

How is NBIX's PE ratio calculated (Neurocrine Biosciences PE ratio formula)?

The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Jun 18, 2024), Neurocrine Biosciences's share price is $130.86. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $3.77. Therefore, Neurocrine Biosciences's PE ratio for today is 34.71. PE RATIO(34.71) = STOCK PRICE($130.86) / TTM EPS($3.77)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.